Showing results (181-190 of 212) with videos related to
Sort By:
Pageof 22
Oncogene|November 3, 2010
Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcomeL A Henry, D A Johnson, D Sarrió, et al.Journal of Medicinal Chemistry|April 26, 1996
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.Journal of Medicinal Chemistry|January 6, 1995
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinasesB D Palmer, G W Rewcastle, A M Thompson, et al.New Zealand Veterinary Journal|June 1, 1997
A zinc-containing intraruminal device for facial eczema control in lambsR Munday, A M Thompson, E A Fowke, et al.Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.Oncogene|September 7, 2010
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancerH C Moore, L B Jordan, S E Bray, et al.British Journal of Cancer|February 25, 2012
Phenformin as prophylaxis and therapy in breast cancer xenograftsM V C L Appleyard, K E Murray, P J Coates, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Anti-peptide antibodies detect oncogene-related proteins in urineH L Niman, A M Thompson, A Yu, et al.Atmospheric Environment (Oxford, England : 1994)|May 28, 2020
Quantifying stratosphere-troposphere transport of ozone using balloon-borne ozonesondes, radar windprofilers and trajectory modelsD W Tarasick, T K Carey-Smith, W K Hocking, et al.Breast (Edinburgh, Scotland)|March 20, 2012
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyA Fong, J Shafiq, C Saunders, et al.Pageof 22